Financial statements Ewopharma Ag
Balance sheet data of EWOPHARMA AG
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 8 980 041,12 | 8 449 536,47 | 8 591 451,88 | 7 940 890,97 | 7 806 447,78 | 7 124 114,64 |
| A. Fixed assets | 2 007 434,29 | 1 738 971,62 | 1 957 378,49 | 1 906 124,57 | 2 344 017,73 | 2 994 125,18 |
| B. Current assets | 6 972 606,83 | 6 710 564,85 | 6 634 073,39 | 6 034 766,40 | 5 462 430,05 | 4 129 989,46 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 8 980 041,12 | 8 449 536,47 | 8 591 451,88 | 7 940 890,97 | 7 806 447,78 | 7 124 114,64 |
| A. Equity | 6 711 746,31 | 5 376 429,55 | 6 246 795,27 | 5 501 854,84 | 4 610 398,88 | 4 568 118,01 |
| B. Liabilities and provisions for liabilities | 2 268 294,81 | 3 073 106,92 | 2 344 656,61 | 2 439 036,13 | 3 196 048,90 | 2 555 996,63 |
| I. Long-term liabilities | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| II. Short-term liabilities | 1 178 726,87 | 2 023 158,10 | 1 299 768,79 | 1 535 358,91 | 2 097 776,90 | 1 488 678,63 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.